Trulance (plecanatide) - Bausch Health
Linzess (linaclotide) - Ironwood Pharma, AbbVie
bisacodyl - Generic mfg.
prucalopride - Generic mfg.
Amitiza (lubiprostone) - Takeda, Mallinckrodt
Ibsrela (tenapanor) - Ardelyx
First Reported Case of MRI Performed on a Patient With Multiple Vibrant Vibrating Capsules In Situ (ACG 2026) - Aug 29, 2026 - Abstract #P5370; Pres time: Oct 13, 2026; 10:30 AM - 04:00 PM; Location: Exhibit Halls A - D (Level 3); "She experienced ineffective responses or side-effects to multiple pharmacologic therapies including polyethylene glycol, senna, bisacodyl (oral and rectal), glycerin suppositories, magnesium salts, linaclotide, plecanatide, lubiprostone, prucalopride, and tenapanor. This report also highlights the need for improved screening for ingestible electronic devices prior to MRI. Figure: X-ray Showing 5 Vibrant Vibrating Capsules In Situ 1 Day After MRI" 
Clinical • Constipation • Endocrine Disorders • Fibromyalgia • Gastroenterology • Gastrointestinal Disorder • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=831125&rnd=0.7330061
 
Benjamin Liu MD 1; Darren Brenner MD 2
 
Aug 29, 2026
 
Prev Next